Cargando…
Upregulation of HMGB1-TLR4 inflammatory pathway in focal cortical dysplasia type II
BACKGROUND: We attempted to determine whether the inflammatory pathway HMGB1-TLR4 and the downstream pro-inflammatory cytokines is upregulated in focal cortical dysplasia (FCD) type II and whether there is a correlation between the TLR4 upregulation and disease duration or frequency of epileptic sei...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791174/ https://www.ncbi.nlm.nih.gov/pubmed/29382328 http://dx.doi.org/10.1186/s12974-018-1078-8 |
_version_ | 1783296576414810112 |
---|---|
author | Zhang, Zhongbin Liu, Qingzhu Liu, Ming Wang, Hui Dong, Ying Ji, Taoyun Liu, Xiaoyan Jiang, Yuwu Cai, Lixin Wu, Ye |
author_facet | Zhang, Zhongbin Liu, Qingzhu Liu, Ming Wang, Hui Dong, Ying Ji, Taoyun Liu, Xiaoyan Jiang, Yuwu Cai, Lixin Wu, Ye |
author_sort | Zhang, Zhongbin |
collection | PubMed |
description | BACKGROUND: We attempted to determine whether the inflammatory pathway HMGB1-TLR4 and the downstream pro-inflammatory cytokines is upregulated in focal cortical dysplasia (FCD) type II and whether there is a correlation between the TLR4 upregulation and disease duration or frequency of epileptic seizures. METHODS: FCD type II and peri-FCD paired tissues resected from eight children with refractory epilepsy were collected. Through real-time qPCR, Western blot, and co-immunoprecipitation, we examined the differences between FCD lesions and peri-FCD tissues with respect to mRNA expression, protein expression, and protein interaction in HMGB1-TLR4 pathway biomarker and downstream pro-inflammatory factors in whole brain tissue. Then, we used immunofluorescence to examine the difference between FCD lesions and peri-FCD tissues with respect to protein expression and intracellular distribution of HMGB1-TLR4 pathway biomarker in neurons, astrocytes, and oligodendrocytes. Correlation between level of TLR4 expression and disease duration or frequency of epileptic seizures in patients was also analyzed. RESULTS: The protein expression levels of TLR4, cytoplasm HMGB1, TLR4/MyD88 complex, ubiquitination of TRAF6, p-IKK, p-IκB-α, p-NF-κB p65, and IL-1β and TNF-α in lesion tissues were significantly higher than those in peri-FCD controls. Total mRNA expression levels of TLR4, IL-1β, and TNF-α in lesion tissues were significantly higher than those in peri-FCD controls, but HMGB1 had no significant change. In neurons and astrocytes inside the lesions, the expression of TLR4 protein was significantly higher than that in peri-FCD tissues, and HMGB1 was mainly expressed in the cytoplasm, while expressed in the nuclei in peri-FCD tissues. But in oligodendrocytes, there was no upregulation of HMGB1-TLR4 pathway in both lesions and peri-FCD tissues. We did not identify the correlation between the level of TLR4 activation and disease duration or frequency of epileptic seizures. CONCLUSION: The HMGB1-TLR4 pathway was upregulated in the neurons and astrocytes inside FCD type II lesions, which led to an increase in the release of downstream pro-inflammatory cytokines. Correlation between the level of TLR4 activation and duration or frequency of epileptic seizures was not identified. |
format | Online Article Text |
id | pubmed-5791174 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-57911742018-02-08 Upregulation of HMGB1-TLR4 inflammatory pathway in focal cortical dysplasia type II Zhang, Zhongbin Liu, Qingzhu Liu, Ming Wang, Hui Dong, Ying Ji, Taoyun Liu, Xiaoyan Jiang, Yuwu Cai, Lixin Wu, Ye J Neuroinflammation Research BACKGROUND: We attempted to determine whether the inflammatory pathway HMGB1-TLR4 and the downstream pro-inflammatory cytokines is upregulated in focal cortical dysplasia (FCD) type II and whether there is a correlation between the TLR4 upregulation and disease duration or frequency of epileptic seizures. METHODS: FCD type II and peri-FCD paired tissues resected from eight children with refractory epilepsy were collected. Through real-time qPCR, Western blot, and co-immunoprecipitation, we examined the differences between FCD lesions and peri-FCD tissues with respect to mRNA expression, protein expression, and protein interaction in HMGB1-TLR4 pathway biomarker and downstream pro-inflammatory factors in whole brain tissue. Then, we used immunofluorescence to examine the difference between FCD lesions and peri-FCD tissues with respect to protein expression and intracellular distribution of HMGB1-TLR4 pathway biomarker in neurons, astrocytes, and oligodendrocytes. Correlation between level of TLR4 expression and disease duration or frequency of epileptic seizures in patients was also analyzed. RESULTS: The protein expression levels of TLR4, cytoplasm HMGB1, TLR4/MyD88 complex, ubiquitination of TRAF6, p-IKK, p-IκB-α, p-NF-κB p65, and IL-1β and TNF-α in lesion tissues were significantly higher than those in peri-FCD controls. Total mRNA expression levels of TLR4, IL-1β, and TNF-α in lesion tissues were significantly higher than those in peri-FCD controls, but HMGB1 had no significant change. In neurons and astrocytes inside the lesions, the expression of TLR4 protein was significantly higher than that in peri-FCD tissues, and HMGB1 was mainly expressed in the cytoplasm, while expressed in the nuclei in peri-FCD tissues. But in oligodendrocytes, there was no upregulation of HMGB1-TLR4 pathway in both lesions and peri-FCD tissues. We did not identify the correlation between the level of TLR4 activation and disease duration or frequency of epileptic seizures. CONCLUSION: The HMGB1-TLR4 pathway was upregulated in the neurons and astrocytes inside FCD type II lesions, which led to an increase in the release of downstream pro-inflammatory cytokines. Correlation between the level of TLR4 activation and duration or frequency of epileptic seizures was not identified. BioMed Central 2018-01-30 /pmc/articles/PMC5791174/ /pubmed/29382328 http://dx.doi.org/10.1186/s12974-018-1078-8 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Zhang, Zhongbin Liu, Qingzhu Liu, Ming Wang, Hui Dong, Ying Ji, Taoyun Liu, Xiaoyan Jiang, Yuwu Cai, Lixin Wu, Ye Upregulation of HMGB1-TLR4 inflammatory pathway in focal cortical dysplasia type II |
title | Upregulation of HMGB1-TLR4 inflammatory pathway in focal cortical dysplasia type II |
title_full | Upregulation of HMGB1-TLR4 inflammatory pathway in focal cortical dysplasia type II |
title_fullStr | Upregulation of HMGB1-TLR4 inflammatory pathway in focal cortical dysplasia type II |
title_full_unstemmed | Upregulation of HMGB1-TLR4 inflammatory pathway in focal cortical dysplasia type II |
title_short | Upregulation of HMGB1-TLR4 inflammatory pathway in focal cortical dysplasia type II |
title_sort | upregulation of hmgb1-tlr4 inflammatory pathway in focal cortical dysplasia type ii |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791174/ https://www.ncbi.nlm.nih.gov/pubmed/29382328 http://dx.doi.org/10.1186/s12974-018-1078-8 |
work_keys_str_mv | AT zhangzhongbin upregulationofhmgb1tlr4inflammatorypathwayinfocalcorticaldysplasiatypeii AT liuqingzhu upregulationofhmgb1tlr4inflammatorypathwayinfocalcorticaldysplasiatypeii AT liuming upregulationofhmgb1tlr4inflammatorypathwayinfocalcorticaldysplasiatypeii AT wanghui upregulationofhmgb1tlr4inflammatorypathwayinfocalcorticaldysplasiatypeii AT dongying upregulationofhmgb1tlr4inflammatorypathwayinfocalcorticaldysplasiatypeii AT jitaoyun upregulationofhmgb1tlr4inflammatorypathwayinfocalcorticaldysplasiatypeii AT liuxiaoyan upregulationofhmgb1tlr4inflammatorypathwayinfocalcorticaldysplasiatypeii AT jiangyuwu upregulationofhmgb1tlr4inflammatorypathwayinfocalcorticaldysplasiatypeii AT cailixin upregulationofhmgb1tlr4inflammatorypathwayinfocalcorticaldysplasiatypeii AT wuye upregulationofhmgb1tlr4inflammatorypathwayinfocalcorticaldysplasiatypeii |